These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 19188825)

  • 1. A pilot evaluation of a novel immunohistochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression (ProEx C) in cervical adenocarcinoma in situ, adenocarcinoma, and benign glandular mimics.
    Aximu D; Azad A; Ni R; Colgan T; Nanji S
    Int J Gynecol Pathol; 2009 Mar; 28(2):114-9. PubMed ID: 19188825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of a novel immunocytochemical assay for topoisomerase II-alpha and minichromosome maintenance protein 2 expression in cervical cytology.
    Shroyer KR; Homer P; Heinz D; Singh M
    Cancer; 2006 Oct; 108(5):324-30. PubMed ID: 16937378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BD ProEx C: a sensitive and specific marker of HPV-associated squamous lesions of the cervix.
    Badr RE; Walts AE; Chung F; Bose S
    Am J Surg Pathol; 2008 Jun; 32(6):899-906. PubMed ID: 18425044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of p16ink4a, ProEX C, and Ki-67 for the diagnosis of glandular dysplasia and adenocarcinoma of the cervix uteri.
    Negri G; Bellisano G; Carico E; Faa G; Kasal A; Antoniazzi S; Egarter-Vigl E; Piccin A; Dalla Palma P; Vittadello F
    Int J Gynecol Pathol; 2011 Jul; 30(4):407-13. PubMed ID: 21623205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of ProExC: a novel immunoperoxidase marker in the evaluation of dysplastic squamous and glandular lesions in cervical specimens.
    Sanati S; Huettner P; Ylagan LR
    Int J Gynecol Pathol; 2010 Jan; 29(1):79-87. PubMed ID: 19952938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical patterns of ProEx C in vulvar squamous lesions: detection of overexpression of MCM2 and TOP2A.
    Chen H; Gonzalez JL; Brennick JB; Liu M; Yan S
    Am J Surg Pathol; 2010 Sep; 34(9):1250-7. PubMed ID: 20697251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of ProEx C with p16INK4a and Ki-67 immunohistochemical staining of cell blocks prepared from residual liquid-based cervicovaginal material: a pilot study.
    Halloush RA; Akpolat I; Jim Zhai Q; Schwartz MR; Mody DR
    Cancer; 2008 Dec; 114(6):474-80. PubMed ID: 19016301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of human papillomavirus on cell cycle-related proteins p16, Ki-67, Cyclin D1, p53, and ProEx C in precursor lesions of cervical carcinoma: a tissue microarray study.
    Conesa-Zamora P; Doménech-Peris A; Orantes-Casado FJ; Ortiz-Reina S; Sahuquillo-Frías L; Acosta-Ortega J; García-Solano J; Pérez-Guillermo M
    Am J Clin Pathol; 2009 Sep; 132(3):378-90. PubMed ID: 19687314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarker (ProEx C, p16(INK4A), and MiB-1) distinction of high-grade squamous intraepithelial lesion from its mimics.
    Pinto AP; Schlecht NF; Woo TY; Crum CP; Cibas ES
    Mod Pathol; 2008 Sep; 21(9):1067-74. PubMed ID: 18552822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and clinical validation of MCM2 and TOP2A monoclonal antibodies in the BD ProEx™ C assay: An immunoassay which detects aberrant S-phase induction in cervical tissue.
    Dixon EP; King LM; Nelson R; Simkins SG; Knapp SL; Brough GH; Lenz KL; Henderson DT; Whitehead CM; Hessling J; Brown CA; Malinowski DP
    J Immunol Methods; 2017 Mar; 442():35-41. PubMed ID: 28093271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of cervical high-grade squamous intraepithelial lesions from cytologic samples using a novel immunocytochemical assay (ProEx C).
    Kelly D; Kincaid E; Fansler Z; Rosenthal DL; Clark DP
    Cancer; 2006 Dec; 108(6):494-500. PubMed ID: 17063495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting high-grade cervical disease on ASC-H cytology: role of BD ProEx C and Digene Hybrid Capture II HPV DNA testing.
    Siddiqui MT; Cohen C; Nassar A
    Am J Clin Pathol; 2008 Nov; 130(5):765-70. PubMed ID: 18854269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of p16INK4a, minichromosome maintenance protein 2, DNA topoisomerase IIalpha, ProEx C, and p16INK4a/ProEx C in cervical squamous intraepithelial lesions.
    Boucher J; Anku-Bertholet C; Temmar R; Pelmus M
    Hum Pathol; 2009 Jun; 40(6):904-5; author reply 905-6. PubMed ID: 19442790
    [No Abstract]   [Full Text] [Related]  

  • 14. p16(INK4a) and ProEx C immunostains facilitate differential diagnosis of hyperchromatic crowded groups in liquid-based Papanicolaou tests with menstrual contamination.
    Ge Y; Mody DR; Smith D; Anton R
    Acta Cytol; 2012; 56(1):55-61. PubMed ID: 22236746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative detection of molecular markers ProEx C (minichromosome maintenance protein 2 and topoisomerase IIa) and MIB-1 in liquid-based cervical squamous cell cytology.
    Beccati MD; Buriani C; Pedriali M; Rossi S; Nenci I
    Cancer; 2008 Jun; 114(3):196-203. PubMed ID: 18442059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ProEx C immunocytochemistry and high-risk human papillomavirus DNA testing in papanicolaou tests with atypical squamous cell (ASC-US) cytology: correlation study with histologic biopsy.
    Siddiqui MT; Hornaman K; Cohen C; Nassar A
    Arch Pathol Lab Med; 2008 Oct; 132(10):1648-52. PubMed ID: 18834224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical staining with MIB1, bcl2 and p16 assists in the distinction of cervical glandular intraepithelial neoplasia from tubo-endometrial metaplasia, endometriosis and microglandular hyperplasia.
    Cameron RI; Maxwell P; Jenkins D; McCluggage WG
    Histopathology; 2002 Oct; 41(4):313-21. PubMed ID: 12383213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 immunoreactivity in normal endocervix and diagnostic value in reactive and neoplastic endocervical lesions.
    Little L; Stewart CJ
    Mod Pathol; 2010 Apr; 23(4):611-8. PubMed ID: 20062011
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratin 17 Is a Prognostic Biomarker in Endocervical Glandular Neoplasia.
    Mockler D; Escobar-Hoyos LF; Akalin A; Romeiser J; Shroyer AL; Shroyer KR
    Am J Clin Pathol; 2017 Sep; 148(3):264-273. PubMed ID: 28821199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucinous expression in benign and neoplastic glandular lesions of the uterine cervix.
    Baker AC; Eltoum I; Curry RO; Stockard CR; Manne U; Grizzle WE; Chhieng D
    Arch Pathol Lab Med; 2006 Oct; 130(10):1510-5. PubMed ID: 17090193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.